Table 12.9a

Unadjusted Graft Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,093 90.6% 0.6% 2,093 81.4% 0.9% 4,067 62.9% 0.9% 5,767 47.5% 0.9%
Primary Diagnosis Emphysema/COPD 831 93.6% 0.9% 831 85.1% 1.3% 1,714 64.8% 1.4% 2,431 47.9% 1.5%
Cystic Fibrosis 330 92.4% 1.5% 330 81.9% 2.2% 645 63.5% 2.3% 922 49.1% 2.4%
Idiopathic Pulmonary Fibrosis 448 88.1% 1.5% 448 79.0% 1.9% 754 60.8% 2.2% 1,035 41.4% 2.4%
Alpha-1-Antitrypsin Deficiency 148 90.5% 2.4% 148 80.9% 3.2% 300 63.5% 3.2% 434 46.3% 3.4%
Primary Pulmonary Hypertension 94 76.5% 4.4% 94 73.0% 4.6% 171 58.4% 4.3% 251 56.0% 3.6%
Congenital Disease 21 85.7% 7.6% 21 81.0% 8.6% 42 56.3% 9.6% 75 45.6% 6.9%
Other 217 89.9% 2.0% 217 76.8% 2.9% 435 61.8% 2.7% 608 50.3% 2.7%
Unknown 4 25.0% 21.7% 4 25.0% 21.7% 6 0.0% 0.0% 11 43.6% 15.5%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.